Elicio Therapeutics ELTX
NASDAQ ELTX
$1.63 +0.02 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Elicio Therapeutics (ELTX) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Elicio Therapeutics (ELTX) recorded Liabilities and Shareholders Equity of $31.33 million in Q2 2026, up 6.1% from $29.53 million a year earlier and up 38.1% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Elicio Therapeutics reported Liabilities and Shareholders Equity of $25.86 million, down 8.2% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -11.4% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $28.18 million in FY2024 (+3.8%), $27.15 million in FY2023 (+19.8%), $22.66 million in FY2022 (-76.5%) and $96.51 million in FY2021 (+103.8%).
  • The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q3 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 10.3%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 103.8% in Q4 2021, against a decline of 76.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $22.69 million (Q1 2026), $25.86 million (Q4 2025) and $28.28 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Elicio Therapeutics 45.57 Mn -42.34 Mn - 39.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 39.60 Mn
Jun 30, 2026 31.33 Mn
Mar 31, 2026 22.69 Mn
Dec 31, 2025 25.86 Mn
Sep 30, 2025 28.28 Mn
Jun 30, 2025 29.53 Mn
Mar 31, 2025 28.14 Mn
Dec 31, 2024 28.18 Mn
Sep 30, 2024 38.39 Mn
Jun 30, 2024 15.75 Mn
Mar 31, 2024 24.48 Mn
Dec 31, 2023 27.15 Mn
Sep 30, 2023 30.99 Mn
Jun 30, 2023 37.62 Mn
Mar 31, 2023 41.77 Mn
Dec 31, 2022 22.66 Mn
Sep 30, 2022 61.32 Mn
Jun 30, 2022 70.81 Mn
Mar 31, 2022 81.26 Mn
Dec 31, 2021 96.51 Mn
API Access

Elicio Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELTX&period=max&api_key=YOUR_API_KEY